Inverse Psoriasiform Eruption During Pembrolizumab Therapy for Metastatic Melanoma

被引：41

作者：

Totonchy, Mariam B. ^{[1
]}

Ezaldein, Harib H. ^{[1
]}

Ko, Christine J. ^{[1
]}

Choi, Jennifer N. ^{[1
,2
]}

机构：

[1] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA

[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

来源：

JAMA DERMATOLOGY | 2016年 / 152卷 / 05期

关键词：

IPILIMUMAB;

D O I：

10.1001/jamadermatol.2015.5210

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：590 / 592

页数：4

共 6 条

[1] Targeting the PD1/PD-L1 axis in melanoma: Biological rationale, clinical challenges and opportunities [J].

Merelli, Barbara ;

Massi, Daniela ;

Cattaneo, Laura ;

Mandala, Mario .

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2014, 89 (01) :140-165

[2] Pembrolizumab versus Ipilimumab in Advanced Melanoma [J].

Robert, Caroline ;

Schachter, Jacob ;

Long, Georgina V. ;

Arance, Ana ;

Grob, Jean Jacques ;

Mortier, Laurent ;

Daud, Adil ;

Carlino, Matteo S. ;

McNeil, Catriona ;

Lotem, Michal ;

Larkin, James ;

Lorigan, Paul ;

Neyns, Bart ;

Blank, Christian U. ;

Hamid, Omid ;

Mateus, Christine ;

Shapira-Frommer, Ronnie ;

Kosh, Michele ;

Zhou, Honghong ;

Ibrahim, Nageatte ;

Ebbinghaus, Scot ;

Ribas, Antoni .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (26) :2521-2532

[3] Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial [J].

Robert, Caroline ;

Ribas, Antoni ;

Wolchok, Jedd D. ;

Hodi, F. Stephen ;

Hamid, Omid ;

Kefford, Richard ;

Weber, Jeffrey S. ;

Joshua, Anthony M. ;

Hwu, Wen-Jen ;

Gangadhar, Tara C. ;

Patnaik, Amita ;

Dronca, Roxana ;

Zarour, Hassane ;

Joseph, Richard W. ;

Boasberg, Peter ;

Chmielowski, Bartosz ;

Mateus, Christine ;

Postow, Michael A. ;

Gergich, Kevin ;

Elassaiss-Schaap, Jeroen ;

Li, Xiaoyun Nicole ;

Iannone, Robert ;

Ebbinghaus, Scot W. ;

Kang, S. Peter ;

Daud, Adil .

LANCET, 2014, 384 (9948) :1109-1117

[4] Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression [J].

Sanlorenzo, Martina ;

Vujic, Igor ;

Daud, Adil ;

Algazi, Alain ;

Gubens, Matthew ;

Luna, Sara Alcantara ;

Lin, Kevin ;

Quaglino, Pietro ;

Rappersberger, Klemens ;

Ortiz-Urda, Susana .

JAMA DERMATOLOGY, 2015, 151 (11) :1206-1212

[5]

Shoushtari AN, 2015, ASCO ANN M MAY 29 JU

[6] Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab [J].

Topalian, Suzanne L. ;

Sznol, Mario ;

McDermott, David F. ;

Kluger, Harriet M. ;

Carvajal, Richard D. ;

Sharfman, William H. ;

Brahmer, Julie R. ;

Lawrence, Donald P. ;

Atkins, Michael B. ;

Powderly, John D. ;

Leming, Philip D. ;

Lipson, Evan J. ;

Puzanov, Igor ;

Smith, David C. ;

Taube, Janis M. ;

Wigginton, Jon M. ;

Kollia, Georgia D. ;

Gupta, Ashok ;

Pardoll, Drew M. ;

Sosman, Jeffrey A. ;

Hodi, F. Stephen .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (10) :1020-+

← 1 →